<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M710</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M710</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tribenzamidomethyl Hydrazine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tanatarec</surname>
            <given-names>Jasmina</given-names>
          </name>
          <xref rid="af1-molbank-2010-M710" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mikova</surname>
            <given-names>Bozhana</given-names>
          </name>
          <xref rid="af2-molbank-2010-M710" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Draeger</surname>
            <given-names>Gerald</given-names>
          </name>
          <xref rid="af3-molbank-2010-M710" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Popovski</surname>
            <given-names>Emil</given-names>
          </name>
          <xref rid="af1-molbank-2010-M710" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2010-M710" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M710"><label>1</label>Institute  of Chemistry, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Arhimedova 5, PO   Box 162, 1000 Skopje, Macedonia</aff>
      <aff id="af2-molbank-2010-M710"><label>2</label>Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Akad.G.Bonchev Str. Bl.9, Sofia 1113, Bulgaria</aff>
      <aff id="af3-molbank-2010-M710"><label>3</label>Institute of Organic Chemistry, Leibniz University of Hannover, D-30167, Hannover, Germany</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M710"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>popovski.emil@gmail.com</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>07</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>4</issue>
      <elocation-id>M710</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A new tribenzamidomethyl hydrazine was synthesized and its IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR and MS spectroscopic data are presented.</p>
      </abstract>
      <kwd-group>
        <kwd>benzamidomethylation</kwd>
        <kwd>hydrazine</kwd>
        <kwd>prodrug</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Many hydrazine derivatives are known to exhibit significant biological activity and several compounds with hydrazine moiety were shown to be effective for treatment of tuberculosis, Parkinson&#x2019;s disease and hypertension [<xref ref-type="bibr" rid="B1-molbank-2010-M710">1</xref>]. There is evidence that some hydrazines displaying neuroprotective properties can be used as antidepressant drugs [<xref ref-type="bibr" rid="B2-molbank-2010-M710">2</xref>], while for some trisubstituted hydrazines antimicrobial effect was observed [<xref ref-type="bibr" rid="B3-molbank-2010-M710">3</xref>]. The hydrazine moiety has been used for modification of peptides as well. For example, novel building blocks for peptide modification have been designed and synthesized to obtain &#x3B2;-sheet tripeptide mimics that comprise the azapeptide modification at one end [<xref ref-type="bibr" rid="B4-molbank-2010-M710">4</xref>]. Azapeptides, hydrazine-based peptidomimetics, were found to be potent agents against hepatitis [<xref ref-type="bibr" rid="B5-molbank-2010-M710">5</xref>], AIDS [<xref ref-type="bibr" rid="B6-molbank-2010-M710">6</xref>] and SARS [<xref ref-type="bibr" rid="B7-molbank-2010-M710">7</xref>]. In addition, hydrazine derivatives have been used for derivatization of nanostructures [<xref ref-type="bibr" rid="B8-molbank-2010-M710">8</xref>]. Therefore, the synthesis of hydrazine derivatives is a matter of significant interest from both theoretical and practical perspectives. On the other hand, the promising usefulness of the benzamidomethyl derivatives as biologically active products [<xref ref-type="bibr" rid="B9-molbank-2010-M710">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2010-M710">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2010-M710">11</xref>] and their implication for pro-drug design [<xref ref-type="bibr" rid="B12-molbank-2010-M710">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2010-M710">13</xref>,<xref ref-type="bibr" rid="B14-molbank-2010-M710">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2010-M710">15</xref>] have been previously reported. Our good results with the benzamidomethylation of amines and hydrazides [<xref ref-type="bibr" rid="B16-molbank-2010-M710">16</xref>,<xref ref-type="bibr" rid="B17-molbank-2010-M710">17</xref>,<xref ref-type="bibr" rid="B18-molbank-2010-M710">18</xref>] using (benzamidomethyl)triethylammonium chloride (<bold>1</bold>), prompted us to synthesize some new products containing hydrazine and benzamidomethyl moieties with an aim to obtain new compounds with potential biological activity. In this short note, the synthesis of a novel tribenzamidomethyl hydrazine is reported. </p>
      <p>Benzamidomethylation reaction of hydrazine, using <bold>1</bold> as a reagent, was performed smoothly in ethanol/aqueous media, under mild reaction conditions at ambient temperature (<xref ref-type="scheme" rid="molbank-2010-M710-sch001">Scheme 1</xref>). The title compound (<bold>3</bold>) was obtained without using a catalyst. Crystals of the product were easily isolated by simple filtration and stored in a dark place at a temperature below 18 &#xB0;C.</p>
      <p>The structure of the newly synthesized compound was confirmed by <sup>1</sup>H NMR, <sup>13</sup>C NMR, FTIR spectroscopy and high-resolution mass spectrometry as well. </p>
    <sec>
      <title>Synthesis</title>
      <sec>
        <title>Materials</title>
        <p>All the reagents and solvents were obtained from commercial sources and used without further purification. (Benzamidomethyl)triethylammonium chloride was prepared according to the literature method [<xref ref-type="bibr" rid="B19-molbank-2010-M710">19</xref>]. Synthetic reaction was monitored by thin-layer chromatography with visualization by UV-light or staining with iodine vapors.</p>
      </sec>
      <sec>
        <title>Instrumentation</title>
        <p>Melting points were determined on a Reichert heating plate and are uncorrected. NMR spectra were recorded on a Bruker 250 MHz instrument using DMSO-<italic>d</italic><sub>6</sub> as solvent and tetramethylsilane as internal standard. Infrared spectra (KBr pellets) were measured on a Perkin-Elmer System 2000 FT-IR. The ESI mass spectra were recorded on a QTof premiere (Waters) equipped with an Acquity UPLC (Waters)." UPLC &#x2013; Gradients and solvents: A = water + 0.1% formic acid; B = methanol + 0.1% formic acid; 0 min = 95% A; 2.5 min = 5% A, 6.5 min = 5% A; 6.6 min = 95% A, 8 min = 95% A.</p>
      </sec>
      <sec>
        <title>Synthesis of tribenzamidomethyl hydrazine <italic>(<bold>3</bold>)</italic></title>
        <p>To a mixture of (benzamidomethyl)triethyl-ammonium chloride (465.1 mg, 1.72 mmol) in 8 mL of water and 0.2 mL of triethylamine, a solution of hydrazine dihydrochloride (59.8 mg, 0.57 mmol) in 8 mL of ethanol was added. Afterwards, the reaction mixture was stirred overnight at room temperature. In this phase, colorless crystals were obtained, which were collected by vacuum filtration. The purification was performed by dissolving the product in ethanol and precipitation with water. </p>
        <p>Melting point of pure crystals: 123&#x2013;125 &#xB0;C. Typical yield 85%.</p>
        <p>FTIR (KBr, cm<sup>&#x2212;1</sup>): <italic>v(</italic>N-H) 3294, 3359, Amide I 1642, Amide II 1542;</p>
        <p><sup>1</sup>H-NMR (250 MHz, DMSO-<italic>d</italic><sub>6</sub>): <italic>&#x3B4;</italic>/ppm 8.81 (t, <italic>J</italic> = 6.0 Hz, 1H, CON<bold><italic>H</italic></bold>CH<sub>2</sub>NHN, overlap), 8.78 (t, <italic>J</italic> = 6.0 Hz, 2H, CON<bold><italic>H</italic></bold>CH<sub>2</sub>NN, overlap) 7.37&#x2013;7.88 (m, 15H, Ar<bold><italic>H</italic></bold>), 4.51 (t, <italic>J</italic> = 5.0 Hz, 1H, NN<bold><italic>H</italic></bold>), 4.36 (d, <italic>J</italic> = 6.0 Hz, 4H, C<bold><italic>H</italic></bold><sub>2</sub>NN, overlap), 4.34 (t, <italic>J</italic> = 5.5 Hz, 2H, C<bold><italic>H</italic></bold><sub>2</sub>NHN, overlap); </p>
        <p><sup>13</sup>C NMR (62.89 MHz, CDCl<sub>3</sub>): <italic>&#x3B4;</italic>/ppm 167.34, 166.41 C=O; 55.68, 58.68 CH<sub>2</sub>; Ar: 134.41; 131.41, 131.29, 128.28; </p>
        <p>HRMS (ESI, pos) m/z: 432.1900 (M+H)<sup>+</sup>; 454.1701 (M+Na)<sup>+</sup>.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2010-M710">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M710-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M710-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M710-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M710-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We are grateful to the Macedonian Ministry of Education and Science (Contract 03-1586) and the Bulgarian National Science Fund (Contract BM-02/07) for financial support. </p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M710">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ragnarsson</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Synthetic methodology for alkyl substituted hydrazines</article-title>
          <source>Chem. Soc. Rev.</source>
          <year>2001</year>
          <volume>30</volume>
          <fpage>205</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="doi">10.1039/b010091a</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M710">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ling</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Urichuk</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Sloley</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Coutts</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>P.K.T.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of N-propargylphenelzine and analogues as neuroprotective agents</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>2715</fpage>
          <lpage>2717</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-894X(01)00549-2</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M710">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#x10C;ernuchov&#xE1;</surname>
              <given-names>P.</given-names>
            </name>
			<name>
              <surname>Vo-Thanh</surname>
              <given-names>G.</given-names>
            </name>
			<name>
              <surname>Milata</surname>
              <given-names>V.</given-names>
            </name>
			<name>
              <surname>Loupy</surname>
              <given-names>A.</given-names>
            </name>
			<name>
              <surname>Jantov&#xE1;</surname>
              <given-names>S.</given-names>
            </name>
			<name>
              <surname>Theiszov&#xE1;</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Utilization of 2-ethoxymethylene-3-oxobutanenitrile in the synthesis of heterocycles possessing biological activity</article-title>
          <source>Tetrahedron</source>
          <year>2005</year>
          <volume>61</volume>
          <fpage>5379</fpage>
          <lpage>5387</lpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M710">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabong</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Jordis</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Phopase</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>NXO Building Blocks for Backbone Modification of Peptides and Preparation of Pseudopeptides</article-title>
          <source>J. Org. Chem.</source>
          <year>2010</year>
          <volume>75</volume>
          <fpage>2492</fpage>
          <lpage>2500</lpage>
          <pub-id pub-id-type="doi">10.1021/jo902518r</pub-id>
          <pub-id pub-id-type="pmid">20297824</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M710">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Durkin</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Windsor</surname>
              <given-names>W.T.</given-names>
            </name>
          </person-group>
          <article-title>Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>1005</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-894X(02)00102-6</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M710">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raja</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lebbos</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kirkpatrick</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Fresh from the Pipeline: Atazanavir sulphate</article-title>
          <source>Nat. Rev. Drug Discov.</source>
          <year>2003</year>
          <volume>2</volume>
          <fpage>857</fpage>
          <lpage>858</lpage>
          <pub-id pub-id-type="doi">10.1038/nrd1232</pub-id>
          <pub-id pub-id-type="pmid">14702957</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M710">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Cherney</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Huitema</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Powers</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Eltis</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>M.N.G.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide</article-title>
          <source>J. Mol. Biol.</source>
          <year>2005</year>
          <volume>353</volume>
          <fpage>1137</fpage>
          <lpage>1151</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2005.09.004</pub-id>
          <pub-id pub-id-type="pmid">16219322</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M710">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roubelakis</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>Y.</given-names>
            </name>
			<name>
              <surname>Komatsu</surname>
              <given-names>K.</given-names>
            </name>
			<name>
              <surname>Orfanopoulos</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Efficient synthesis of open-cage fullerene derivatives having 16-membered-ring orifices</article-title>
          <source>J. Org. Chem.</source>
          <year>2007</year>
          <volume>72</volume>
          <fpage>7042</fpage>
          <lpage>7045</lpage>
          <pub-id pub-id-type="pmid">17665956</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M710">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tiwari</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>K.V.</given-names>
            </name>
            <name>
              <surname>Bajpai</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mishra</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological properties of 4-(3<italic>H</italic>)-quinazolone derivatives</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2007</year>
          <volume>42</volume>
          <fpage>1234</fpage>
          <lpage>1238</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2007.01.002</pub-id>
          <pub-id pub-id-type="pmid">17321640</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M710">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mai</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Artico</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cerbara</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Befani</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Turini</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vedova</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Agostinelli</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biochemical evaluation of (<italic>R</italic>)-5-acyloxymethyl- and (<italic>S</italic>)-5-acylaminomethyl-3-(1<italic>H</italic>-pyrrol-1-yl)-2-oxazolidinones as new anti-monoamine oxidase (anti-MAO) agents</article-title>
          <source>ARKIVOC</source>
          <year>2004</year>
          <volume>2004</volume>
          <fpage>32</fpage>
          <lpage>43</lpage>
        </citation>
      </ref>
      <ref id="B11-molbank-2010-M710">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zlotin</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Sharova</surname>
              <given-names>V.I.</given-names>
            </name>
            <name>
              <surname>Luk`yanov</surname>
              <given-names>A.O.</given-names>
            </name>
          </person-group>
          <article-title>Chemical properties of <italic>N</italic>-(amidomethy)- and <italic>N</italic>-(imidomethyl)glycine derivatives 2. Reactions at alkoxycarbonyl and carboxyl groups</article-title>
          <source>Rus. Chem. Bul.</source>
          <year>1996</year>
          <volume>45</volume>
          <fpage>1680</fpage>
          <lpage>1687</lpage>
        </citation>
      </ref>
      <ref id="B12-molbank-2010-M710">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schioppacassi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Morvillo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bruna</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Franceschi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Foglio</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title><italic>In vitro</italic> and <italic>in vivo</italic> evaluation of benzamidomethyl-benzylpenicillinate (FI7303). A new 'repository' form</article-title>
          <source>Chemotherapy</source>
          <year>1978</year>
          <volume>24</volume>
          <fpage>338</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">250463</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2010-M710">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bundgaard</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Buur</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Aspirin prodrugs: synthesis and hydrolysis of 2-acetoxybenzoate esters of various <italic>N</italic>-(hydroxyalkyl) amides</article-title>
          <source>Int. J. Pharm.</source>
          <year>1988</year>
          <volume>44</volume>
          <fpage>151</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1016/0378-5173(88)90111-1</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2010-M710">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Calheiros</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cabrita</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mendes</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Iley</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Acyloxymethyl as a drug protecting group. Part 3. Tertiary <italic>O</italic>-Amidomethyl esters of penicillin G: Chemical hydrolysis and anti-bacterial activity</article-title>
          <source>Pharm. Res.</source>
          <year>1996</year>
          <volume>13</volume>
          <fpage>70</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">8668682</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2010-M710">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Getz</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Prankerd</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Sloan</surname>
              <given-names>K.B.</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of hydrolysis of benzamidomethyl derivatives of phenols and its implications for prodrug design</article-title>
          <source>J. Org. Chem.</source>
          <year>1992</year>
          <volume>57</volume>
          <fpage>1702</fpage>
          <lpage>1706</lpage>
          <pub-id pub-id-type="doi">10.1021/jo00032a020</pub-id>
        </citation>
      </ref>
      <ref id="B16-molbank-2010-M710">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popovski</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Klisarova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Vikic-Topic</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Benzamidomethylation with (benzamidomethyl)triethylammonium chloride. 2. A simple method for benzamidomethylation of thiols, amines and carboxylic acods</article-title>
          <source>Molecules</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>927</fpage>
          <lpage>936</lpage>
        </citation>
      </ref>
      <ref id="B17-molbank-2010-M710">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popovski</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of N-(N&#x2019;-benoylhydrazinomethyl)benzamide</article-title>
          <source>Molbank</source>
          <year>2007</year>
          <volume>2007</volume>
          <fpage>M525</fpage>
          <pub-id pub-id-type="doi">10.3390/M525</pub-id>
        </citation>
      </ref>
      <ref id="B18-molbank-2010-M710">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popovski</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of N-[N&#x2019;-(2-hydroxy-2,2-diphenylacethyl)hydrazinomethyl]benzamide</article-title>
          <source>Molbank</source>
          <year>2007</year>
          <volume>2007</volume>
          <fpage>M526</fpage>
          <pub-id pub-id-type="doi">10.3390/M526</pub-id>
        </citation>
      </ref>
      <ref id="B19-molbank-2010-M710">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popovski</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Klisarova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Vikic-Topic</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Simple Method for Benzamidomethylation of Phenols in Water Solution</article-title>
          <source>Synth. Commun.</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>3451</fpage>
          <lpage>3458</lpage>
          <pub-id pub-id-type="doi">10.1080/00397919908085975</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2010-M710-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2010-M710-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthetic route to the title compound <bold>3</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M710-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
